Growing community of inventors

Natick, MA, United States of America

Alexandra Kuznetsova

Average Co-Inventor Count = 5.91

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Alexandra KuznetsovaMichael Frid (4 patents)Alexandra KuznetsovaMaria Vilenchik (4 patents)Alexandra KuznetsovaYuriy Gankin (3 patents)Alexandra KuznetsovaMarc Duey (3 patents)Alexandra KuznetsovaMichal Galezowski (1 patent)Alexandra KuznetsovaWojciech Czardybon (1 patent)Alexandra KuznetsovaCharles-Henry Fabritius (1 patent)Alexandra KuznetsovaAgnieszka Dreas (1 patent)Alexandra KuznetsovaAnna Buda (1 patent)Alexandra KuznetsovaGeorgiy Kachkovskyi (1 patent)Alexandra KuznetsovaUrszula Kulesza (1 patent)Alexandra KuznetsovaKatarzyna Kucwaj-Brysz (1 patent)Alexandra KuznetsovaAgnieszka Szamborska-Gbur (1 patent)Alexandra KuznetsovaAndrzej Dzienia (1 patent)Alexandra KuznetsovaMicheal Frid (0 patent)Alexandra KuznetsovaAlexandra Kuznetsova (4 patents)Michael FridMichael Frid (5 patents)Maria VilenchikMaria Vilenchik (4 patents)Yuriy GankinYuriy Gankin (3 patents)Marc DueyMarc Duey (3 patents)Michal GalezowskiMichal Galezowski (6 patents)Wojciech CzardybonWojciech Czardybon (5 patents)Charles-Henry FabritiusCharles-Henry Fabritius (4 patents)Agnieszka DreasAgnieszka Dreas (2 patents)Anna BudaAnna Buda (1 patent)Georgiy KachkovskyiGeorgiy Kachkovskyi (1 patent)Urszula KuleszaUrszula Kulesza (1 patent)Katarzyna Kucwaj-BryszKatarzyna Kucwaj-Brysz (1 patent)Agnieszka Szamborska-GburAgnieszka Szamborska-Gbur (1 patent)Andrzej DzieniaAndrzej Dzienia (1 patent)Micheal FridMicheal Frid (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Felicitex Therapeutics, Inc. (4 from 4 patents)

2. Selvita S.a. (1 from 5 patents)

3. Ryvu Therapeutics S.a. (3 patents)


4 patents:

1. 11202779 - Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors

2. 10577365 - Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases

3. 10322128 - Combinations for the treatment of neoplasms using quiescent cell targeting with EGFR inhibitors

4. 10314843 - Combinations for the treatment of neoplasms using quiescent cell targeting and inhibitors of mitosis

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…